Patent 11766441 was granted and assigned to Genus Lifesciences Inc. on September, 2023 by the United States Patent and Trademark Office.
Stable oral liquid compositions including chlorpromazine or a pharmaceutically acceptable salt or solvate of chlorpromazine, and methods of administering the compositions, are disclosed.